DOCK 180 Antibodies

Santa Cruz Biotechnology features a diverse variety of DOCK 180 monoclonal antibodies for investigating cellular processes. DOCK 180 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DOCK 180 is a crucial guanine nucleotide exchange factor that plays a significant role in regulating cell migration and cytoskeletal dynamics. DOCK 180 participates in the activation of small GTPases, which are essential for various signaling pathways that govern cellular responses to external stimuli. Research focused on DOCK 180 has revealed its importance in immune response mechanisms, wound healing processes, and cancer metastasis. Scientists worldwide utilize DOCK 180 monoclonal antibodies to advance their understanding of cell signaling pathways and molecular interactions. Ongoing studies of DOCK 180 continue to uncover new insights into cellular regulation and disease progression. Research laboratories can leverage Santa Cruz Biotechnology monoclonal antibodies to drive discoveries that benefit the scientific community and enhance our understanding of fundamental biological processes.